Methods for treatment of pulmonary disease using GM-CSF
Patent Number: 6019965
Date of First Priority Issue: Monday October 24th, 1994
Date Issued: Tuesday February 1st, 2000
Assignee: Ludwig Institute for Cancer Research (New York, NY)
Inventors: Dunn, Ashley Roger (Parkville, AU); Stanley, Edouard Guy (London, GB); Lieschke, Graham John (Parkville, AU); Grail, Dianne (Parkville, AU); Fowler, Kerry J. (Parkville, AU)
From Class: Use
Comments: No comments
This patent teaches that the administration of the clinically-used cytokine GM-CSF is useful for the treatment of alveolar proteinosis. This patent would be great to use in combination with systemically administered stem cell therapy since most stem cells given intravenously end up in either the lung or the liver.
View this patent on the USPTO website.
Added to StemCellPatents.com on Monday October 16th, 2006
Social & Bookmarking:
Add Comment
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.